Columbia Research Enhanced Value ETF
REVS
1 hedge funds and large institutions have $373K invested in Columbia Research Enhanced Value ETF in 2020 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
31.86% less ownership
Funds ownership: 98.15% → 66.29% (-32%)
50% less funds holding
Funds holding: 2 → 1 (-1)
92% less capital invested
Capital invested by funds: $4.42M → $373K (-$4.04M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$170K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.22M |
REVS Hedge Fund Activity: Q3 2020 in Review
1 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q3 2020, worth a combined $373K — down 92% from $4.42M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of REVS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, adding an estimated $170K. The largest seller was Ameriprise, exiting entirely with an estimated $4.22M sold.
- 1 institutional investor held Columbia Research Enhanced Value ETF (REVS) as of Q3 2020, down from 2 in Q2 2020.
- Funds reported $373K of Columbia Research Enhanced Value ETF stock for Q3 2020, down 92% quarter-over-quarter.
- 0 funds opened new Columbia Research Enhanced Value ETF positions in Q3 2020 and 1 closed out, a net change of -1 holder.
- The largest Columbia Research Enhanced Value ETF buyer in Q3 2020 was Jane Street, an estimated $170K added.
- The largest Columbia Research Enhanced Value ETF seller in Q3 2020 was Ameriprise, an estimated $4.22M sold.
Based on aggregated 13F filings for Q3 2020.